Elekta (OTCMKTS:EKTAY) Shares Gap Down – Here’s Why

Elekta AB (OTCMKTS:EKTAY) gapped down before the market opened on Monday . The stock had previously closed at $4.8150, but opened at $4.59. Elekta shares last traded at $4.59, with a volume of 389 shares.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Zacks Research upgraded Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 16th. UBS Group started coverage on Elekta in a research report on Wednesday, September 3rd. They set a “sell” rating for the company. Three research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Elekta presently has an average rating of “Reduce”.

Elekta Price Performance

The business’s 50-day simple moving average is $5.04 and its two-hundred day simple moving average is $5.04. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of 76.51 and a beta of 1.12. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.05 and a quick ratio of 0.82.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings results on Thursday, August 28th. The company reported $0.03 earnings per share (EPS) for the quarter. Elekta had a net margin of 1.40% and a return on equity of 11.49%. The company had revenue of $379.64 million during the quarter. Research analysts expect that Elekta AB will post 0.36 earnings per share for the current year.

Elekta Dividend Announcement

The company also recently declared a dividend, which was paid on Friday, September 26th. Stockholders of record on Tuesday, September 9th were paid a dividend of $0.0744 per share. This represents a dividend yield of 289.0%. The ex-dividend date of this dividend was Monday, September 8th. Elekta’s dividend payout ratio (DPR) is presently 200.00%.

About Elekta

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.